Pulse nav.journalClub Debates activos Tendencias Explorar Preguntas Investigadores

Download the App

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

© Synapse Social LLC, 2026

Política de privacidad

Inicio Explorar nav.journalClub Tendencias

⌘+K

Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis | Synapse

December 18, 2002Open Access

Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Caspofungin is at least as effective as amphotericin B for the treatment of invasive candidiasis and, more specifically, candidemia.

Leer artículo completoexternamente

Me gusta

Guardar

Compartir

Ver artículo completo

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Mora-Duarte et al. (Wed,) studied this question.

synapsesocial.com/papers/69d88bfa18b0ca7f91d18159 https://doi.org/https://doi.org/10.1056/nejmoa021585

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Management of Invasive Candidal Infections: Results of a Prospective, Randomized, Multicenter Study of Fluconazole Versus Amphotericin B and Review of the Literature1996 · 276 citations
2Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study1995 · 77 citations
3A prospective study of the efficacy of fluconazole (UK-49,858) against deep-seated fungal infections1988 · 92 citations
4Amphotericin B: 30 Years of Clinical Experience1990 · 1,013 citations
5International surveillance of blood stream infections due to Candida species in the European SENTRY program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents1999 · 264 citations